EconPapers    
Economics at your fingertips  
 

An efficient C-glycoside production platform enabled by rationally tuning the chemoselectivity of glycosyltransferases

Min Li, Yang Zhou, Zexing Wen, Qian Ni, Ziqin Zhou, Yiling Liu, Qiang Zhou, Zongchao Jia, Bin Guo, Yuanhong Ma, Bo Chen, Zhi-Min Zhang () and Jian-bo Wang ()
Additional contact information
Min Li: Hunan Normal University
Yang Zhou: Jinan University
Zexing Wen: Hunan Normal University
Qian Ni: Hunan Normal University
Ziqin Zhou: Jinan University
Yiling Liu: Jinan University
Qiang Zhou: Chinese Academy of Sciences
Zongchao Jia: Kingston
Bin Guo: Hunan Normal University
Yuanhong Ma: Hunan Normal University
Bo Chen: Hunan Normal University
Zhi-Min Zhang: Jinan University
Jian-bo Wang: Hunan Normal University

Nature Communications, 2024, vol. 15, issue 1, 1-13

Abstract: Abstract Despite the broad potential applications of C-glycosides, facile synthetic methods remain scarce. Transforming glycosyltransferases with promiscuous or natural O-specific chemoselectivity to C-glycosyltransferases is challenging. Here, we employ rational directed evolution of the glycosyltransferase MiCGT to generate MiCGT-QDP and MiCGT-ATD mutants which either enhance C-glycosylation or switch to O-glycosylation, respectively. Structural analysis and computational simulations reveal that substrate binding mode govern C-/O-glycosylation selectivity. Notably, directed evolution and mechanism analysis pinpoint the crucial residues dictating the binding mode, enabling the rational design of four enzymes with superior non-inherent chemoselectivity, despite limited sequence homology. Moreover, our best mutants undergo testing with 34 substrates, demonstrating superb chemoselectivities, regioselectivities, and activities. Remarkably, three C-glycosides and an O-glycoside are produced on a gram scale, demonstrating practical utility. This work establishes a highly selective platform for diverse glycosides, and offers a practical strategy for creating various types of glycosylation platforms to access pharmaceutically and medicinally interesting products.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-024-53209-1 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-53209-1

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-024-53209-1

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-53209-1